Clinical Trials

5 enrolled

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT06578351 2026-02-04

TRAM

60 enrolled

Dermatitis, Atopic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04139434 2026-01-23

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

32 enrolled

Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05923112 2025-12-05

BESPONSA Injection 1 mg Special Investigation

421 enrolled 18 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05687032 2025-12-03

A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 4 Completed

44 enrolled 14 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04984356 2025-09-30

A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

28 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02303821 2025-06-04

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

141 enrolled 37 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03384654 2025-05-25

A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

47 enrolled 22 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05166135 2025-03-25

LOYAL

589 enrolled 62 charts

Burkitt Lymphoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05597085 2025-02-04

A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

32 enrolled 31 charts

Burkitt Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05775406 2025-01-27

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

52 enrolled

Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01266083 2024-11-19

WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)

22 enrolled 8 charts

Pathologic Complete Response, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04465370 2024-11-18

POGO

89 enrolled 12 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00285259 2024-10-21

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

LymphoidMyeloidOther hematologic neoplasm

112 enrolled

Communicable Diseases, Cytomegalovirus Infections, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Viremia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05326516 2024-08-13

A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia

30 enrolled

Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06527781 2024-07-30

A Study of PD5K3 in Healthy Adult Volunteers

28 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05850013 2024-07-18

VISION-Jr

504 enrolled

111 enrolled 23 charts 1 FDA

Cardiovascular Diseases, Respiration Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02393859 2024-05-29

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Phase 3 Completed

Immunoproliferative Disorders, Lymphoproliferative Disorders, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02000427 2024-05-28

Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

45 enrolled 24 charts 1 FDA

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05064787 2024-05-24

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Phase NA Completed

45 enrolled

Leukemia, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06392763 2024-04-30

Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data

602 enrolled

Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04524455 2024-04-08

Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL

17 enrolled 17 charts

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02435849 2024-02-13

ELIANA

80 enrolled 39 charts 1 FDA

GastrointestinalLymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01735955 2024-02-08

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Phase 4 Completed

57 enrolled 8 charts

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Piebaldism, Gastrointestinal Stromal Tumors, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03833180 2024-01-12

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

91 enrolled

Burkitt Lymphoma, Leukemia, Leukemia, Lymphoid, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04956666 2023-12-29

ALL

75 enrolled 12 charts

Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03677596 2023-11-22

A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients

Phase 4 Completed

102 enrolled 27 charts

229 enrolled 17 charts 2 FDA

Leukemia, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04145531 2023-11-18

An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Phase 2/3 Completed

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06035614 2023-09-13

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Phase NA Completed

50 enrolled

Autoimmune Diseases, Skin Diseases, Vitiligo, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04954326 2023-07-12

ALL

89 enrolled 13 charts

Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03236857 2023-05-22

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

CNSLymphoidOther hematologic neoplasm

143 enrolled

Lymphoma, Non-Hodgkin, Neoplasms, Neuroblastoma, Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04357041 2023-05-17

CoVS

440 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04067518 2023-04-20

A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia

28 enrolled 14 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04323657 2023-03-16

TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

6 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04770922 2023-02-16

Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

80 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00002663 2023-02-13

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

DermatologicLymphoidOther hematologic neoplasmSarcoma

58 enrolled 18 charts

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Recurrence, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT02743351 2023-02-08

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasm

96 enrolled 13 charts

Bronchiolitis Obliterans Syndrome, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03476239 2023-02-08

Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Phase 3 Completed

121 enrolled 27 charts

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01607892 2023-01-26

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

286 enrolled 26 charts

Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05563545 2022-11-28

Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia

2 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02003612 2022-11-07

Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia

2,373 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04456959 2022-09-28

InO

28 enrolled 55 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02010931 2022-09-15

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

310 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05349201 2022-07-01

CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)

273 enrolled

Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02813252 2022-06-03

Long-Term Follow-up Study for Patients Previously Treated With JCAR015

15 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00042341 2022-05-27

Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)

60 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04014764 2022-04-05

(ANSWer)

LymphoidMyeloidOther hematologic neoplasmPlasma cell

119 enrolled

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04819854 2022-03-24

Single and Multiple Ascending Dose Study With EP395

78 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04888468 2022-03-18

Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

9 enrolled